Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Nobles Medical Technologies II
AddedFeb 18, 2024
UpdatedJun 18, 2026
Nobles Medical Technologies II

Nobles Medical Technologies II

Nobles Medical II, a California-based manufacturer, develops suture-based systems for PFO closure and offers vascular suturing products.

HQ
Fountain Valley, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees

Nobles Medical Technologies II, based in Fountain Valley, California, focuses on developing suture-based systems for patent foramen ovale (PFO) closure. Their product line includes SuperStitch, which aids in vascular suturing for puncture or incision sites, and NobleStitch, designed for placing a single polypropylene suture through the septum secundum and septum primum.

Nobles Medical II has made significant strides in the medical device industry, particularly in enhancing the safety and efficacy of PFO closure procedures. Their innovative suturing technologies have positively impacted patient outcomes, positioning the company as a key player in the cardiovascular medical device market.

Nobles Medical Technologies II - Similar Companies

Nectero Medical logo

Nectero Medical

necteromed.com

Venock logo

Venock

venock.com

Novostent logo

Novostent

Suture Concepts logo

Suture Concepts

Bi02 Medical logo

Bi02 Medical

bio2medical.com

Nutech Medical logo

Nutech Medical

Advanced Medical Device Technologies logo

Advanced Medical Device Technologies

advancedmdt.com

Figure 8 Surgical logo

Figure 8 Surgical

Svelte Medical Systems logo

Svelte Medical Systems

EmboMedics logo

EmboMedics

Neograft Technologies logo

Neograft Technologies

Nitinol Devices & Components logo

Nitinol Devices & Components

VenX logo

VenX

Traverse Vascular logo

Traverse Vascular

Arbor Surgical Technologies logo

Arbor Surgical Technologies

Nobles Medical Technologies II - Quick Facts

Who are Nobles Medical Technologies II's competitors?

Companies similar to Nobles Medical Technologies II include Nectero Medical, Venock, Novostent and Suture Concepts.

When was Nobles Medical Technologies II founded?

Nobles Medical Technologies II was founded in 2009.

Where is Nobles Medical Technologies II's headquarters located?

Nobles Medical Technologies II's headquarters is located in Fountain Valley, CA, US.

When was Nobles Medical Technologies II's last funding round?

Nobles Medical Technologies II's most recent funding round was for $398.9k (USD) in October 2012.

How much has Nobles Medical Technologies II raised to-date?

As of Oct 29, 2012, Nobles Medical Technologies II has raised a total of $398.9k (USD).

How many employees does Nobles Medical Technologies II have?

Nobles Medical Technologies II has 6 employees as of Feb 5, 2024.

Nobles Medical Technologies II - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified